Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

The dark side of the moon: looking beyond beneficial effects of cannabis use in multiple sclerosis.

Penner IK, Hartung HP.

Brain. 2019 Sep 1;142(9):2552-2555. doi: 10.1093/brain/awz234. No abstract available.

PMID:
31497861
2.

Production Strategies for Pentamer-Positive Subviral Dense Bodies as a Safe Human Cytomegalovirus Vaccine.

Gogesch P, Penner I, Krauter S, Büscher N, Grode L, Aydin I, Plachter B.

Vaccines (Basel). 2019 Sep 1;7(3). pii: E104. doi: 10.3390/vaccines7030104.

3.

Dense Bodies of a gH/gL/UL128/UL130/UL131 Pentamer-Repaired Towne Strain of Human Cytomegalovirus Induce an Enhanced Neutralizing Antibody Response.

Lehmann C, Falk JJ, Büscher N, Penner I, Zimmermann C, Gogesch P, Sinzger C, Plachter B.

J Virol. 2019 Aug 13;93(17). pii: e00931-19. doi: 10.1128/JVI.00931-19. Print 2019 Sep 1.

PMID:
31189713
4.

In search of distinct MS-related fatigue subtypes: results from a multi-cohort analysis in 1.403 MS patients.

Pust GEA, Pöttgen J, Randerath J, Lau S, Heesen C, Gold SM, Penner IK.

J Neurol. 2019 Jul;266(7):1663-1673. doi: 10.1007/s00415-019-09311-2. Epub 2019 Apr 19.

PMID:
31004211
5.

Central Slab versus Whole Brain to Measure Brain Atrophy in Multiple Sclerosis.

Ruberte E, Sinnecker T, Amann M, Gaetano L, Naegelin Y, Penner IK, Kuhle J, Derfuss T, Kappos L, Granziera C, Wuerfel J, Yaldizli Ö.

Eur Neurol. 2018;80(3-4):207-214. doi: 10.1159/000495798. Epub 2019 Jan 3.

PMID:
30605898
6.

Adherence to Subcutaneous IFN β-1a in Multiple Sclerosis: Final Analysis of the Non-Interventional Study READOUTsmart Using the Dosing Log and Readout Function of RebiSmart®.

Rieckmann P, Schwab M, Pöhlau D, Penner IK, Wagner T, Schel E, Bayas A.

Adv Ther. 2019 Jan;36(1):175-186. doi: 10.1007/s12325-018-0839-1. Epub 2018 Nov 28.

PMID:
30488338
7.

The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): results from the German validation study.

Filser M, Schreiber H, Pöttgen J, Ullrich S, Lang M, Penner IK.

J Neurol. 2018 Nov;265(11):2587-2593. doi: 10.1007/s00415-018-9034-1. Epub 2018 Aug 31.

PMID:
30171410
8.

Improving fatigue in multiple sclerosis by smartphone-supported energy management: The MS TeleCoach feasibility study.

D'hooghe M, Van Gassen G, Kos D, Bouquiaux O, Cambron M, Decoo D, Lysandropoulos A, Van Wijmeersch B, Willekens B, Penner IK, Nagels G.

Mult Scler Relat Disord. 2018 May;22:90-96. doi: 10.1016/j.msard.2018.03.020. Epub 2018 Mar 27.

9.

Randomised controlled trial of a self-guided online fatigue intervention in multiple sclerosis.

Pöttgen J, Moss-Morris R, Wendebourg JM, Feddersen L, Lau S, Köpke S, Meyer B, Friede T, Penner IK, Heesen C, Gold SM.

J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):970-976. doi: 10.1136/jnnp-2017-317463. Epub 2018 Mar 16.

PMID:
29549193
10.

Cognition in multiple sclerosis.

Penner IK.

Neurodegener Dis Manag. 2017 Nov;7(6s):19-21. doi: 10.2217/nmt-2017-0036. No abstract available.

PMID:
29143583
11.

Information processing deficits as a driving force for memory impairment in MS: A cross--sectional study of memory functions and MRI in early and late stage MS.

Köhler W, Fischer M, Bublak P, Faiss JH, Hoffmann F, Kunkel A, Sailer M, Schwab M, Stadler E, Zettl UK, Penner IK; HIPPOCOMS Study Group.

Mult Scler Relat Disord. 2017 Nov;18:119-127. doi: 10.1016/j.msard.2017.09.026. Epub 2017 Sep 25.

PMID:
29141793
12.

Validation of the fatigue scale for motor and cognitive functions in a danish multiple sclerosis cohort.

Oervik MS, Sejbaek T, Penner IK, Roar M, Blaabjerg M.

Mult Scler Relat Disord. 2017 Oct;17:130-134. doi: 10.1016/j.msard.2017.07.017. Epub 2017 Jul 17.

PMID:
29055443
13.

Fatigue as a symptom or comorbidity of neurological diseases.

Penner IK, Paul F.

Nat Rev Neurol. 2017 Nov;13(11):662-675. doi: 10.1038/nrneurol.2017.117. Epub 2017 Oct 13. Review.

PMID:
29027539
14.

Characterization of social cognition impairment in multiple sclerosis.

Neuhaus M, Bagutti S, Yaldizli Ö, Zwahlen D, Schaub S, Frey B, Fischer-Barnicol B, Burgunder JM, Martory MD, Pöttgen J, Annoni JM, Penner IK.

Eur J Neurol. 2018 Jan;25(1):90-96. doi: 10.1111/ene.13457. Epub 2017 Oct 24.

PMID:
28898535
15.

Functional reorganization is a maladaptive response to injury - NO.

Penner IK, Aktas O.

Mult Scler. 2017 Feb;23(2):193-194. doi: 10.1177/1352458516679895. Epub 2016 Dec 8. Review. No abstract available.

PMID:
27932693
16.

Retrieval of the particle size distribution function from the data of lidar sensing under the assumption of known refractive index.

Samoilova SV, Sviridenkov MA, Penner IE.

Appl Opt. 2016 Oct 1;55(28):8022-8029. doi: 10.1364/AO.55.008022.

PMID:
27828041
17.

Fluctuations of spontaneous EEG topographies predict disease state in relapsing-remitting multiple sclerosis.

Gschwind M, Hardmeier M, Van De Ville D, Tomescu MI, Penner IK, Naegelin Y, Fuhr P, Michel CM, Seeck M.

Neuroimage Clin. 2016 Aug 9;12:466-77. doi: 10.1016/j.nicl.2016.08.008. eCollection 2016.

18.

Evaluation of cognition and fatigue in multiple sclerosis: daily practice and future directions.

Penner IK.

Acta Neurol Scand. 2016 Sep;134 Suppl 200:19-23. doi: 10.1111/ane.12651. Review.

PMID:
27580902
19.

Pediatric multiple sclerosis: Cognition and mood.

Amato MP, Krupp LB, Charvet LE, Penner I, Till C.

Neurology. 2016 Aug 30;87(9 Suppl 2):S82-7. doi: 10.1212/WNL.0000000000002883. Review.

PMID:
27572867
20.

A pilot study on the benefit of cognitive rehabilitation in Parkinson's disease.

Adamski N, Adler M, Opwis K, Penner IK.

Ther Adv Neurol Disord. 2016 May;9(3):153-64. doi: 10.1177/1756285616628765. Epub 2016 Feb 16.

21.
22.

Targeting Nonsense Mutations in Diseases with Translational Read-Through-Inducing Drugs (TRIDs).

Nagel-Wolfrum K, Möller F, Penner I, Baasov T, Wolfrum U.

BioDrugs. 2016 Apr;30(2):49-74. doi: 10.1007/s40259-016-0157-6. Review.

PMID:
26886021
23.

The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.

Yaldizli Ö, Penner IK, Yonekawa T, Naegelin Y, Kuhle J, Pardini M, Chard DT, Stippich C, Kira JI, Bendfeldt K, Amann M, Radue EW, Kappos L, Sprenger T.

Eur J Neurol. 2016 Mar;23(3):510-9. doi: 10.1111/ene.12891. Epub 2015 Nov 19.

PMID:
26699999
24.

Multiple sclerosis and fatigue: A review on the contribution of inflammation and immune-mediated neurodegeneration.

Patejdl R, Penner IK, Noack TK, Zettl UK.

Autoimmun Rev. 2016 Mar;15(3):210-20. doi: 10.1016/j.autrev.2015.11.005. Epub 2015 Nov 14. Review.

PMID:
26589194
25.

Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review.

Ziemssen T, Rauer S, Stadelmann C, Henze T, Koehler J, Penner IK, Lang M, Poehlau D, Baier-Ebert M, Schieb H, Meuth S.

PLoS One. 2015 Sep 22;10(9):e0138243. doi: 10.1371/journal.pone.0138243. eCollection 2015. Review.

26.

Managing Neuropsychological Impairment in Multiple Sclerosis: Pilot Study on a Standardized Metacognitive Intervention.

Pöttgen J, Lau S, Penner I, Heesen C, Moritz S.

Int J MS Care. 2015 May-Jun;17(3):130-7. doi: 10.7224/1537-2073.2014-015.

27.

Case-Based fMRI Analysis after Cognitive Rehabilitation in MS: A Novel Approach.

Hubacher M, Kappos L, Weier K, Stöcklin M, Opwis K, Penner IK.

Front Neurol. 2015 Apr 8;6:78. doi: 10.3389/fneur.2015.00078. eCollection 2015.

28.

[Fatigue in patients with multiple sclerosis--pathogenesis, clinical picture, diagnosis and treatment].

Patejdl R, Penner IK, Noack TK, Zettl UK.

Fortschr Neurol Psychiatr. 2015 Apr;83(4):211-20. doi: 10.1055/s-0034-1399353. Epub 2015 Apr 20. Review. German.

PMID:
25893494
29.

Cognitive rehabilitation of working memory in juvenile multiple sclerosis-effects on cognitive functioning, functional MRI and network related connectivity.

Hubacher M, DeLuca J, Weber P, Steinlin M, Kappos L, Opwis K, Penner IK.

Restor Neurol Neurosci. 2015;33(5):713-25. doi: 10.3233/RNN-150497.

PMID:
25835556
30.

Improvement in Fatigue during Natalizumab Treatment is Linked to Improvement in Depression and Day-Time Sleepiness.

Penner IK, Sivertsdotter EC, Celius EG, Fuchs S, Schreiber K, Berkö S, Svenningsson A; TYNERGY trial investigators.

Front Neurol. 2015 Feb 23;6:18. doi: 10.3389/fneur.2015.00018. eCollection 2015.

31.

Understanding intellectual enrichment: how cognitive reserve impacts on hippocampal volume in multiple sclerosis.

Muhlert N, Penner IK.

Eur J Neurol. 2016 Jan;23(1):9-10. doi: 10.1111/ene.12674. Epub 2015 Feb 12. No abstract available.

PMID:
25683751
32.

Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis.

Rocca MA, Amato MP, De Stefano N, Enzinger C, Geurts JJ, Penner IK, Rovira A, Sumowski JF, Valsasina P, Filippi M; MAGNIMS Study Group.

Lancet Neurol. 2015 Mar;14(3):302-17. doi: 10.1016/S1474-4422(14)70250-9. Epub 2015 Feb 4. Review.

PMID:
25662900
33.

Towards the implementation of 'no evidence of disease activity' in multiple sclerosis treatment: the multiple sclerosis decision model.

Stangel M, Penner IK, Kallmann BA, Lukas C, Kieseier BC.

Ther Adv Neurol Disord. 2015 Jan;8(1):3-13. doi: 10.1177/1756285614560733.

34.

Layers of quasi-horizontally oriented ice crystals in cirrus clouds observed by a two-wavelength polarization lidar.

Borovoi A, Balin Y, Kokhanenko G, Penner I, Konoshonkin A, Kustova N.

Opt Express. 2014 Oct 6;22(20):24566-73. doi: 10.1364/OE.22.024566.

PMID:
25322032
35.

Defining the new end point for multiple sclerosis treatment.

Stangel M, Penner IK, Kieseier BC.

JAMA Neurol. 2014 Aug;71(8):1056-7. doi: 10.1001/jamaneurol.2014.1542. No abstract available.

PMID:
25111213
36.

Translational read-through as an alternative approach for ocular gene therapy of retinal dystrophies caused by in-frame nonsense mutations.

Nagel-Wolfrum K, Möller F, Penner I, Wolfrum U.

Vis Neurosci. 2014 Sep;31(4-5):309-16. doi: 10.1017/S0952523814000194. Epub 2014 Jun 10. Review.

PMID:
24912600
37.

Reduced magnetisation transfer ratio in cognitively impaired patients at the very early stage of multiple sclerosis: a prospective, multicenter, cross-sectional study.

Faiss JH, Dähne D, Baum K, Deppe R, Hoffmann F, Köhler W, Kunkel A, Lux A, Matzke M, Penner IK, Sailer M, Zettl UK.

BMJ Open. 2014 Apr 10;4(4):e004409. doi: 10.1136/bmjopen-2013-004409.

38.

Default mode network alterations during language task performance in children with benign epilepsy with centrotemporal spikes (BECTS).

Oser N, Hubacher M, Specht K, Datta AN, Weber P, Penner IK.

Epilepsy Behav. 2014 Apr;33:12-7. doi: 10.1016/j.yebeh.2014.01.008. Epub 2014 Feb 26.

PMID:
24583653
39.

Cerebellar abnormalities contribute to disability including cognitive impairment in multiple sclerosis.

Weier K, Penner IK, Magon S, Amann M, Naegelin Y, Andelova M, Derfuss T, Stippich C, Radue EW, Kappos L, Sprenger T.

PLoS One. 2014 Jan 22;9(1):e86916. doi: 10.1371/journal.pone.0086916. eCollection 2014.

40.

One step forward in the quest for evidence of the efficacy of cognitive rehabilitation in multiple sclerosis.

Penner IK, Sastre-Garriga J.

Mult Scler. 2014 Jan;20(1):2. doi: 10.1177/1352458513510982. No abstract available.

PMID:
24347477
41.

Working memory training in patients with chronic schizophrenia: a pilot study.

Hubacher M, Weiland M, Calabrese P, Stoppe G, Stöcklin M, Fischer-Barnicol D, Opwis K, Penner IK.

Psychiatry J. 2013;2013:154867. doi: 10.1155/2013/154867. Epub 2013 Feb 26.

42.

Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration.

Achtnichts L, Gonen O, Rigotti DJ, Babb JS, Naegelin Y, Penner IK, Bendfeldt K, Hirsch J, Amann M, Kappos L, Gass A.

Eur J Radiol. 2013 Dec;82(12):e848-52. doi: 10.1016/j.ejrad.2013.08.037. Epub 2013 Sep 4.

43.

The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.

Yaldizli Ö, Penner IK, Frontzek K, Naegelin Y, Amann M, Papadopoulou A, Sprenger T, Kuhle J, Calabrese P, Radü EW, Kappos L, Gass A.

Mult Scler. 2014 Mar;20(3):356-64. doi: 10.1177/1352458513496880. Epub 2013 Aug 19.

PMID:
23959709
44.

Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.

Hofstetter L, Naegelin Y, Filli L, Kuster P, Traud S, Smieskova R, Mueller-Lenke N, Kappos L, Gass A, Sprenger T, Penner IK, Nichols TE, Vrenken H, Barkhof F, Polman C, Radue EW, Borgwardt SJ, Bendfeldt K.

Mult Scler. 2014 Feb;20(2):202-13. doi: 10.1177/1352458513493034. Epub 2013 Jun 26.

45.

Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting.

Svenningsson A, Falk E, Celius EG, Fuchs S, Schreiber K, Berkö S, Sun J, Penner IK; Tynergy Trial Investigators.

PLoS One. 2013;8(3):e58643. doi: 10.1371/journal.pone.0058643. Epub 2013 Mar 21.

46.

Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.

Papadopoulou A, Müller-Lenke N, Naegelin Y, Kalt G, Bendfeldt K, Kuster P, Stoecklin M, Gass A, Sprenger T, Radue EW, Kappos L, Penner IK.

Mult Scler. 2013 Sep;19(10):1290-6. doi: 10.1177/1352458513475490. Epub 2013 Mar 4.

PMID:
23459568
47.

BECTS evolving to Landau-Kleffner Syndrome and back by subsequent recovery: a longitudinal language reorganization case study using fMRI, source EEG, and neuropsychological testing.

Datta AN, Oser N, Ramelli GP, Gobbin NZ, Lantz G, Penner IK, Weber P.

Epilepsy Behav. 2013 Apr;27(1):107-14. doi: 10.1016/j.yebeh.2012.12.025. Epub 2013 Feb 9.

PMID:
23399945
48.

Cognitive impairment and cortical reorganization in children with benign epilepsy with centrotemporal spikes.

Datta AN, Oser N, Bauder F, Maier O, Martin F, Ramelli GP, Steinlin M, Weber P, Penner IK.

Epilepsia. 2013 Mar;54(3):487-94. doi: 10.1111/epi.12067. Epub 2013 Jan 7.

49.

The Stroop task: comparison between the original paradigm and computerized versions in children and adults.

Penner IK, Kobel M, Stöcklin M, Weber P, Opwis K, Calabrese P.

Clin Neuropsychol. 2012;26(7):1142-53. doi: 10.1080/13854046.2012.713513. Epub 2012 Aug 28.

PMID:
22928670
50.

Brief International Cognitive Assessment for MS (BICAMS): international standards for validation.

Benedict RH, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, Hamalainen P, Hartung H, Krupp L, Penner I, Reder AT, Langdon D.

BMC Neurol. 2012 Jul 16;12:55. doi: 10.1186/1471-2377-12-55.

Supplemental Content

Loading ...
Support Center